Scopia Capital Management’s CONMED CNMD Stock Holding History

Scopia Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-310,392	Closed	-$34.8M	–	19
2020 Q4	$34.8M	Sell	310,392 -336,803	-52%	-$31.9M	4.4%	8
2020 Q3	$50.9M	Hold	647,195	–	–	6.02%	9
2020 Q2	$46.6M	Buy	+647,195	New	+$45M	5.13%	7
2019 Q1	–	Sell	-969,160	Closed	-$62.2M	–	26
2018 Q4	$62.2M	Sell	969,160 -235,691	-20%	-$16.1M	2.11%	17
2018 Q3	$95.4M	Sell	1,204,851 -519,194	-30%	-$40.2M	1.84%	19
2018 Q2	$126M	Sell	1,724,045 -450,000	-21%	-$30.6M	2.21%	19
2018 Q1	$138M	Sell	2,174,045 -600,000	-22%	-$35.8M	2.75%	20
2017 Q4	$141M	Hold	2,774,045	–	–	2.54%	15
2017 Q3	$146M	Hold	2,774,045	–	–	2.3%	14
2017 Q2	$141M	Hold	2,774,045	–	–	2.91%	13
2017 Q1	$123M	Hold	2,774,045	–	–	2.28%	16
2016 Q4	$123M	Hold	2,774,045	–	–	2.32%	14
2016 Q3	$111M	Hold	2,774,045	–	–	1.96%	18
2016 Q2	$132M	Buy	2,774,045 +393,781	+17%	+$16.7M	2.73%	15
2016 Q1	$99.8M	Buy	+2,380,264	New	+$93.4M	1.86%	22

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Scopia Capital Management's CNMD Position: Q1 2021 in Review

Scopia Capital Management sold out of CONMED (CNMD) in Q1 2021, closing a stake of 310,392 shares — an estimated $34.8M sold.

Scopia Capital Management first reported a position in CNMD in Q1 2016 and held it in 15 quarters. The position peaked at $146M in Q3 2017. 239 funds tracked by Wall St. Rank hold CNMD as of Q1 2021.

Scopia Capital Management reported no remaining CONMED position as of Q1 2021 after selling out during the quarter.
Scopia Capital Management sold 310,392 CONMED shares in Q1 2021, an estimated $34.8M.
Scopia Capital Management first reported a position in CONMED in Q1 2016 and held it in 15 quarters.
Scopia Capital Management's CONMED position peaked at $146M in Q3 2017.
239 funds tracked by Wall St. Rank held CONMED as of Q1 2021.

Based on Scopia Capital Management's 13F filing for Q1 2021, filed 17 May 2021.